Cabergoline Effect on Blood Sugar in Type 2 Diabetics

Not Applicable

• Conditions: Diabetes Type 2

• Registration Number: NCT01459601
• Lead Sponsor: Mashhad University of Medical Sciences

Brief Summary

Diabetic patients with poorly control blood sugar are prescribed cabergoline for 1 months and their blood glucose is evaluated.

Detailed Description

Not available

Study Timeline

• Status Verified: 2011-10
• Study First Submitted: 2011-10-24
• Study First Submitted QC: 2011-10-24
• Last Update Submitted: 2011-10-24
• Study First Posted: 2011-10-25
• Last Update Posted: 2011-10-25
• Study Start: 2012-01
• Primary Completion: 2012-02
• Study Completion: 2012-02

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 10

Inclusion Criteria

• Type 2 diabetes
• HbA1C>7

Exclusion Criteria

• HbA1C>10
• Psychiatric disorders

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
FBS (fasting blood sugar)	30days

Secondary Outcome Measures

Name	Time	Method
HbA1C	30days